8 luglio 2025|
AI
|5 months agoNovartis receives approval for breakthrough infant malaria drug
Swiss regulator greenlights Coartem Baby, marking significant advancement in treating malaria in infants weighing between two and five kilos
AI
Generated IllustrationKey Takeaways
AI
- Swissmedic has approved Coartem Baby for infants weighing between two and five kilos.
- The drug is also known as Riamet Baby in certain international markets.
- The approval process involved collaboration with regulatory authorities from eight African nations.
- The WHO's Global Malaria Programme participated in the scientific evaluation.
By The Numbers
2 to 5
kilograms
8
countries
30+
years
They Said
"For more than 30 years we have stayed the course in the fight against malaria, working tirelessly to deliver scientific breakthroughs where they are most needed."
"Together with our partners, we are proud to have gone further, developing the first clinically tested malaria treatment for infants and children, ensuring that even the smallest and most vulnerable can finally receive the treatment they deserve."